Multivalent Antibody–Nanoparticle Conjugates To Enhance the Sensitivity of Surface-Enhanced Raman Scattering-Based Immunoassays
Source abstract
Abstract
Multivalent immunoprobes can improve the sensitivity of biosensors because increased valency can strengthen the binding affinity between the receptor and target biomolecules. Here, we report surface-enhanced Raman scattering (SERS)-based immunoassays using multivalent antibody-conjugated nanoparticles (NPs) for the first time. Multivalent antibodies were generated through the ligation of Fab fragments fused with Fc-binding peptides to immunoglobulin G. This fabrication method is easy and fast because of the elimination of heterologous protein expression, high degrees of antibody modifications, and covalent chemical ligation steps. We constructed multivalent antibody-NP conjugates (MANCs) and employed them as SERS immunoprobes. MANCs improved the sensitivity of SERS-based immunoassays by 100 times compared to standard antibody-NP conjugates. MANCs will increase the feasibility of practical SERS-based immunoassays.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, KAIST, Daejeon 34141, Korea
Department of Nanobiotechnology, KRIBB School of Biotechnology, UST, Daejeon 34113, Korea
Funding
Korea Research Institute of Bioscience and Biotechnology · National Research Foundation of Korea · Ministry of Environment · Ministry of Science and ICT
References (25)
Show source-provided references
1. 10.1021/acs.chemrev.7b0002710.1021/acs.chemrev.7b00027 ↗
2. 10.1006/meth.2000.103910.1006/meth.2000.1039 ↗
3. 10.1016/j.bios.2015.07.04010.1016/j.bios.2015.07.040 ↗
4. 10.1039/c4cs00369a10.1039/c4cs00369a ↗
5. 10.1002/ange.20170915310.1002/ange.201709153 ↗
6. 10.1039/c7nr08066b10.1039/c7nr08066b ↗
7. 10.1021/acsnano.7b0153610.1021/acsnano.7b01536 ↗
8. 10.1002/anie.20140855810.1002/anie.201408558 ↗
9. 10.1021/acscentsci.7b0058410.1021/acscentsci.7b00584 ↗
10. 10.1039/c7nr09162a10.1039/c7nr09162a ↗
11. 10.1371/journal.pone.000538110.1371/journal.pone.0005381 ↗
12. 10.2174/138527201337480610.2174/1385272013374806 ↗
13. 10.1021/ac402192k10.1021/ac402192k ↗
14. 10.1073/pnas.110535110810.1073/pnas.1105351108 ↗
15. 10.1016/j.tibtech.2010.03.00710.1016/j.tibtech.2010.03.007 ↗
16. 10.1016/j.drudis.2015.02.01310.1016/j.drudis.2015.02.013 ↗
17. 10.4049/jimmunol.170.9.485410.4049/jimmunol.170.9.4854 ↗
18. 10.1158/0008-5472.can-08-203310.1158/0008-5472.can-08-2033 ↗
19. 10.1016/s0022-1759(99)00135-010.1016/s0022-1759(99)00135-0 ↗
20. Dan L. · Cancer Res. · 2001 · 61 · 7002
21. 10.1016/s0022-1759(02)00148-510.1016/s0022-1759(02)00148-5 ↗
22. 10.1158/0008-5472.can-05-106910.1158/0008-5472.can-05-1069 ↗
23. 10.1158/0008-5472.can-04-250010.1158/0008-5472.can-04-2500 ↗
24. 10.1038/nature0887810.1038/nature08878 ↗
25. 10.1021/acs.chemmater.7b0293210.1021/acs.chemmater.7b02932 ↗